Search results
Small Business - Austin Daily Herald | Austin Daily Herald
Austin Daily Herald· 2 hours agoAML is a cancer of the blood and bone marrow and is the most common type of acute leukemia in adults. SENTI-202, a potential first-in-class ...
Venetoclax Combo Safe, Effective in AML Patients Age 80 and Up, Real-World Data Show
MedPage Today· 4 days agoVenetoclax (Venclexta) combined with a hypomethylating agent (HMA) -- the standard of care for older...
AML/T cell interactomics uncover correlates of patient outcomes and the key role of ICAM1 in T cell...
Nature· 4 days agoT cells are important for the control of acute myeloid leukemia (AML), a common and often deadly malignancy. We observed that some < ...
Study: Older Adults With Aggressive Blood Cancer A | Newswise
Newswise· 3 days agoStandard of care treatment for acute myeloid leukemia (AML) is safe and effective for adults over...
Moleculin Reports First Quarter 2024 Financial Results and Provides Corporate Update
WJET - WFXP Erie· 3 hours agoMoleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug candidates targeting hard-to-treat tumors and viruses ...
Earnings call: Kura Oncology reports on ziftomenib's progress By Investing.com
Investing.com· 7 days agoZiftomenib has received Breakthrough Therapy designation from the FDA for the treatment of...
Researchers discover new target for potential leukemia therapy
Medical Xpress· 5 days agoThe study provides both mechanistic and preclinical evidence supporting the rapid initiation of...
Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and...
WTNH-TV New Haven· 5 days agoSyndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an...
... Management and Deerfield Foundation Announce Second Annual AML Summit and Recipients of American...
The Pilot News· 7 days agoDeerfield Management and the Deerfield Foundation announced today they will honor the 2023-2024 recipients of the American Society of Hematology (ASH) Peter Steelman Scholar Award at the second ...
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 day agoSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2024 Earnings Call Transcript May 8, 2024 Syndax...